US 9272023
Use of ixolaris, a tissue factor inhibitor, for inhibiting angiogenesis
granted A61KA61K38/1767A61K38/57
Quick answer
US patent 9272023 (Use of ixolaris, a tissue factor inhibitor, for inhibiting angiogenesis) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K38/1767, A61K38/57, A61K45/06, A61P